Lineage, Inc. Common Stock (LINE)vsRexford Industrial Realty Inc (REXR)
LINE
Lineage, Inc. Common Stock
$42.63
-1.32%
REAL ESTATE · Cap: $11.14B
REXR
Rexford Industrial Realty Inc
$34.07
-0.44%
REAL ESTATE · Cap: $8.12B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 438% more annual revenue ($5.36B vs $995.92M). REXR leads profitability with a 23.3% profit margin vs -2.7%. REXR earns a higher WallStSmart Score of 63/100 (C+).
LINE
Avoid34
out of 100
Grade: F
REXR
Buy63
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
+71.5%
Fair Value
$131.72
Current Price
$34.07
$97.65 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Strong operational efficiency at 41.5%
Keeps 23 of every $100 in revenue as profit
Earnings expanding 28.0% YoY
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
Expensive relative to growth rate
Premium valuation, high expectations priced in
Distress zone — elevated risk
ROE of 2.8% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : REXR
The strongest argument for REXR centers on Price/Book, Operating Margin, Profit Margin. Profitability is solid with margins at 23.3% and operating margin at 41.5%.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : REXR
The primary concerns for REXR are PEG Ratio, P/E Ratio, Altman Z-Score.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while REXR is a declining play — different risk/reward profiles.
LINE is growing revenue faster at 0.4% — sustainability is the question.
REXR generates stronger free cash flow (78M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
REXR scores higher overall (63/100 vs 34/100), backed by strong 23.3% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company specializing in regenerative medicine, with a focus on developing state-of-the-art cell therapies for conditions such as ocular diseases, spinal cord injuries, and various cancers. Leveraging its proprietary technologies and strong strategic partnerships, Lineage aims to revolutionize patient care with pioneering therapeutic solutions. The company’s dedication to advancing its diverse product pipeline and accelerating clinical trials positions it as a compelling investment prospect for institutional investors looking to engage at the cutting edge of healthcare advancements.
Visit Website →Rexford Industrial Realty Inc
REAL ESTATE · REIT - INDUSTRIAL · USA
Rexford Industrial, a real estate investment trust that focuses on owning and operating industrial properties in the infill markets of Southern California, owns 232 properties with approximately 27.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?